Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Furuya

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Archives of Microbiology|April 1, 2010
Isolation of a novel bacterium, Blautia glucerasei sp. nov., hydrolyzing plant glucosylceramide to ceramideHideki Furuya, Yukari Ide, Makiko Hamamoto, et al.
The Journal of General and Applied Microbiology|June 9, 2005
A new strain of Butyrivibrio fibrisolvens that has high ability to isomerize linoleic acid to conjugated linoleic acidShinji Fukuda, Hideki Furuya, Yuhgi Suzuki, et al.
The Journal of Nutrition|December 1, 2005
Oral administration of butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of miceSou Ohkawara, Hideki Furuya, Kousuke Nagashima, et al.
Clinical and Vaccine Immunology : CVI|September 22, 2006
Effect of oral administration of Butyrivibrio fibrisolvens MDT-1 on experimental enterocolitis in miceSou Ohkawara, Hideki Furuya, Kousuke Nagashima, et al.
International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift Fur Vitamin- Und Ernahrungsforschung. Journal International De Vitaminologie Et De Nutrition|July 26, 2008
Dietary sphingomyelin alleviates experimental inflammatory bowel disease in miceHideki Furuya, Sou Ohkawara, Kousuke Nagashima, et al.
Nutrition and Cancer|October 12, 2007
Effect of oral administration of Butyrivibrio fibrisolvens MDT-1, a gastrointestinal bacterium, on 3-methylcholanthrene-induced tumor in miceSou Ohkawara, Hideki Furuya, Kousuke Nagashima, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 2019
Immunogenomic Analysis of Exceptional Responder to ALT-803 (IL-15 Analogue) in BCG Unresponsive Nonmuscle Invasive Bladder Cancer: A Case Series and Review of the LiteratureJeffrey Huang, Stephen L Shiao, Hideki Furuya, et al.
Biomolecules|June 28, 2014
The impact of sphingosine kinase-1 in head and neck cancerPaulette M Tamashiro, Hideki Furuya, Yoshiko Shimizu, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Clinical Utility of Oncuria™, a Multiplexed Liquid Biopsy for the Non-Invasive Detection of Bladder Cancer-A Pilot StudyKaoru Murakami, Ian Pagano, Hideki Furuya, et al.
Oncotarget|December 24, 2015
A novel nuclear Src and p300 signaling axis controls migratory and invasive behavior in pancreatic cancerDavid Paladino, Peibin Yue, Hideki Furuya, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Archives of Microbiology|April 1, 2010
Isolation of a novel bacterium, Blautia glucerasei sp. nov., hydrolyzing plant glucosylceramide to ceramideHideki Furuya, Yukari Ide, Makiko Hamamoto, et al.
The Journal of General and Applied Microbiology|June 9, 2005
A new strain of Butyrivibrio fibrisolvens that has high ability to isomerize linoleic acid to conjugated linoleic acidShinji Fukuda, Hideki Furuya, Yuhgi Suzuki, et al.
The Journal of Nutrition|December 1, 2005
Oral administration of butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of miceSou Ohkawara, Hideki Furuya, Kousuke Nagashima, et al.
Clinical and Vaccine Immunology : CVI|September 22, 2006
Effect of oral administration of Butyrivibrio fibrisolvens MDT-1 on experimental enterocolitis in miceSou Ohkawara, Hideki Furuya, Kousuke Nagashima, et al.
International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift Fur Vitamin- Und Ernahrungsforschung. Journal International De Vitaminologie Et De Nutrition|July 26, 2008
Dietary sphingomyelin alleviates experimental inflammatory bowel disease in miceHideki Furuya, Sou Ohkawara, Kousuke Nagashima, et al.
Nutrition and Cancer|October 12, 2007
Effect of oral administration of Butyrivibrio fibrisolvens MDT-1, a gastrointestinal bacterium, on 3-methylcholanthrene-induced tumor in miceSou Ohkawara, Hideki Furuya, Kousuke Nagashima, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 2019
Immunogenomic Analysis of Exceptional Responder to ALT-803 (IL-15 Analogue) in BCG Unresponsive Nonmuscle Invasive Bladder Cancer: A Case Series and Review of the LiteratureJeffrey Huang, Stephen L Shiao, Hideki Furuya, et al.
Biomolecules|June 28, 2014
The impact of sphingosine kinase-1 in head and neck cancerPaulette M Tamashiro, Hideki Furuya, Yoshiko Shimizu, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Clinical Utility of Oncuria™, a Multiplexed Liquid Biopsy for the Non-Invasive Detection of Bladder Cancer-A Pilot StudyKaoru Murakami, Ian Pagano, Hideki Furuya, et al.
Oncotarget|December 24, 2015
A novel nuclear Src and p300 signaling axis controls migratory and invasive behavior in pancreatic cancerDavid Paladino, Peibin Yue, Hideki Furuya, et al.
Pageof 8